Teaching cancer cells to die

Leigh Zawel1

  • 1Novartis Institute for Biomedical Research, Oncology Biology, East Hanover, New Jersey 07936, USA. leigh.zawel@pharma.novartis.com

Insights

Cancer cells resist cell death through various mechanisms. This review discusses how targeting these apoptotic defects presents therapeutic opportunities for cancer drug development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Tumor cells possess multiple strategies to evade programmed cell death (apoptosis).
  • Understanding the molecular regulation of apoptosis is crucial for cancer therapy.
  • Defects in apoptosis pathways are a hallmark of cancer.

Purpose of the Study:

  • To review the mechanisms by which tumor cells evade apoptosis.
  • To discuss the therapeutic potential of targeting apoptotic defects in cancer.
  • To highlight the challenges and opportunities in developing drugs that exploit these alterations.

Main Methods:

  • Literature review of cancer cell apoptosis evasion.
  • Analysis of molecular pathways regulating programmed cell death.
  • Discussion of drug development strategies targeting apoptosis.

Main Results:

  • Tumor cells utilize diverse mechanisms to inhibit apoptosis.
  • Targeting these apoptotic defects is a promising area for cancer drug discovery.
  • Exploiting these vulnerabilities requires overcoming specific biological hurdles.

Conclusions:

  • Apoptotic defects in cancer cells offer viable targets for novel therapeutics.
  • Further research into apoptosis regulation can yield new anti-cancer strategies.
  • Developing effective drugs requires a deep understanding of cancer's evasion tactics.

Related Concept Videos

What is Cancer?02:12

What is Cancer?

Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of patients who died from...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...